Emerging evidence of a link between the polycystins and the mTOR pathways

Alessandra Boletta1

  • 1Dulbecco Telethon Institute (DTI) at Dibit, San Raffaele Scientific Institute, Via Olgettina 58, 20132 Milan, Italy. boletta.alessandra@hsr.it.

Pathogenetics
|October 30, 2009
PubMed

Insights

Autosomal dominant polycystic kidney disease (ADPKD) involves cyst formation due to PKD1/PKD2 gene mutations. Polycystins (PC-1, PC-2) regulate cell growth via mTOR signaling, offering potential therapeutic targets for ADPKD.

Area of Science:

  • Cell Biology
  • Genetics
  • Biochemistry

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by renal cyst development.
  • Mutations in PKD1 and PKD2 genes, encoding polycystin-1 (PC-1) and polycystin-2 (PC-2), are primary causes of ADPKD.
  • PC-1 is a plasma membrane receptor, and PC-2 is a calcium channel; their complex normally prevents cyst formation, but mechanisms are unclear.

Purpose of the Study:

  • To review recent advances in understanding polycystin functions and their role in signal transduction.
  • To explore the connection between polycystins, mTOR signaling, and ADPKD pathogenesis.
  • To discuss the potential regulation of mTOR complexes by PC-1 and cross-talk with other genes.

Main Methods:

  • Literature review focusing on recent studies of polycystins, mTOR signaling, and ADPKD.
  • Analysis of research on the interaction between PC-1, mTORC1, and mTORC2.
  • Examination of studies investigating the link between PKD genes, TSC genes, cilia, cell size, and cell cycle regulation.

Main Results:

  • Increased mammalian target of rapamycin (mTOR) kinase activity is observed in ADPKD cysts.
  • PC-1 directly regulates cell growth via mTOR and may differentially regulate mTORC1 and mTORC2.
  • Evidence suggests genetic and functional cross-talk between PKD and TSC genes, and a potential link between cilia, cell size, and cell cycle.

Conclusions:

  • Polycystins play a crucial role in regulating cell growth and signaling pathways relevant to ADPKD.
  • Targeting mTOR signaling, potentially modulated by PC-1, shows therapeutic promise for ADPKD.
  • Further research into the interplay of polycystins, mTOR, cilia, and cell cycle regulation is warranted for ADPKD treatment strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...